MEEX Speaker
GRINDSTAFF, Kent, PhD
Vice Presindent, Business Development and Operations - USA, SOLVO Biotechnology, USA
Biography
Mr. Grindstaff will act as the chairman of the 2nd Day of the conference. With more than 12 years experience in early-stage drug development and transporter biology at Biopharmaceutical and Contract Research organizations, Dr. Grindstaff manages SOLVO’s operations in the Untied States and Canada since June 2012. Prior to joining SOLVO USA, he was head of research at Optivia Biotechnology, a transporter focused CRO and Biotechnology company based in Menlo Park, CA, USA. From 2000 to 2010, he held numerous scientific positions, most recently as Principal Investigator, at XenoPort Inc., Santa Clara, CA, USA. Dr. Grindstaff has a Ph.D. in Molecular Cell Biology and Biochemistry from Washington University, Saint Louis, MO, USA and completed a Senior Post-doctoral Fellowship in the Department of Molecular and Cellular Physiology at Stanford University, Palo Alto, CA, USA. He has authored numerous peer-reviewed publications, reviews, and grant applications related to epithelial barrier models and transporters.
